Vote in the European Parliament

Plants obtained by certain new genomic techniques and their food and feed, and amending Regulation (EU) 2017/625

Jessica Polfjärd – After Recital 18 – Am 19
Date: 17.06.2026·Reference: A10-0175/2026
Rapporteur: Jessica Polfjärd

Overall Result

Rejected
  • 185 For
  • 450 Against
  • 21 Abstention
  • 63 Did not vote
Amendment— You are viewing a sub-vote (amendment) of the main vote.Amendment 19 · Tabled by The LeftView amendment at the EP ↗
Amendment wording

Tabled by Anja Hazekamp, Emma Fourreau, João Oliveira, Lynn Boylan, Kathleen Funchion, Konstantinos Arvanitis, Per Clausen, Sebastian Everding

Added: (18a) The European Parliament has called for the Union and its Member States not to grant patents on biological material and to safeguard the freedom to operate and the breeders’ exemption for varieties. It should be ensured that breeders have full access to the genetic material of NGT plants, which by definition are not transgenic plants. Access to genetic materials can best be secured when the right of patent holders is exhausted in the hand of the breeder (breeder’s exemption). As current provisions in patent law do not provide for a full breeder’s exemption, it should be ensured that patents should not restrict the use of NGT plants by breeders and farmers. Hence, NGT plants should not be subject to patent legislation, but should for the protection of intellectual property solely be subject to the Community Plant Variety Rights (CPVR) system, as laid down in Council Regulation (EC) No 2100/94, which allows the use of the breeder’s exemption. NGT plants, their derived seeds, their plant material, associated genetic material such as genes and gene sequences, and plant traits should therefore be excluded from patentability. The exclusion from patentability should be applied in a consistent manner across legislation. Furthermore, in order to avoid patents being granted or patent applications being submitted between the date of the entry into force of this Regulation and the application of its provisions, it should be ensured that plant material is excluded from patentability from the day of entry into force of this Regulation. For patents already granted or pending patent applications covering plant material, the effects of patents should be further limited. In addition, the Commission should assess and address, in the forthcoming study, how the broader problem of patents being granted, directly or indirectly, on plant material despite previous efforts to close loopholes, should be further addressed. The assessment should address in particular the role and impact of patents on breeders' and farmers' access to plant reproductive material, seed diversity and affordable prices, as well as on innovation and in particular on opportunities for SMEs. The report of the Commission should be accompanied by the appropriate legislative proposals in order to ensure further necessary adjustments are made to the intellectual property rights framework.

Wording as published by the EP, in English. PE783.371

← Back to Main Vote
Status and procedure

Outcome as recorded by the European Parliament.

Vote held on
Latest recorded step
Official Journal · (140 days ago)
Next scheduled step
No further step is scheduled in the source.
Publication in the Official Journal recorded

Procedure timeline

2023/0226(COD) · COD

Recorded procedure activities. These do not establish whether a law has entered into force.

  1. Recorded: Referral6 days until the next step
  2. Recorded: Committee stage96 days until the next step
  3. Recorded: Plenary9 days until the next step
  4. Recorded: Negotiations77 days until the next step
  5. Recorded: Plenary377 days until the next step
  6. Recorded: Negotiations267 days until the next step
  7. Recorded: Committee stage92 days until the next step
  8. Recorded: Referral22 days until the next step
  9. Recorded: Committee stage24 days until the next step
  10. Recorded: Plenary2 days until the next step
  11. Recorded: SignatureNext step on the same day
  12. Recorded: Other activity9 days until the next step
  13. Latest recorded: Official Journal
Recorded activities (32)
  1. Referral to committee
  2. Committee report tabled
  3. Committee amendments tabled
  4. Committee amendments tabled
  5. Committee amendments tabled
  6. Committee amendments tabled
  7. Committee opinion adopted
  8. Committee report adopted
  9. Tabling for plenary
  10. Plenary debate
  11. Text amended in plenary
  12. Referred back to committee for interinstitutional negotiations
  13. Plenary vote
  14. Plenary vote results
  15. Parliament’s first-reading position
  16. Plenary vote
  17. Plenary vote results
  18. Interinstitutional negotiations
  19. Interinstitutional negotiations
  20. Interinstitutional negotiations
  21. Interinstitutional negotiations
  22. Provisional agreement approved in committee
  23. Referral to committee
  24. Committee amendments tabled
  25. Committee report tabled
  26. Committee report adopted
  27. Tabling for plenary
  28. Other recorded activity
  29. Signature
  30. Plenary vote
  31. Plenary vote results
  32. Publication in the Official Journal
Scheduled activities (not confirmation of completion)
  1. Plenary debate
  2. Plenary vote
  3. Plenary vote
  4. Plenary vote

Procedure file (OEIL) · European Parliament data
Retrieved:

Sources

Data: EP Open Data API

What is this about?

  • Adoption of regulation on genomic plants following agreement.
  • Implementation of new genomic techniques from 2026 .
  • Criticism of subsidiarity principle violation by member states.
Source: AI Summary with Mistral

Vote by political group

How the political groups voted

Members

Showing 10 of 719

Vote Position
NameCountryGroupVote Position
PolandNI
For
GermanyRenew
For
GermanyS&D
For
SlovakiaNI
For
RomaniaNI
For
SlovakiaRenew
For
BulgariaESN
For
SpainNI
For
LithuaniaGreens/EFA
For
FranceGreens/EFA
For
Show more
Follow us on Instagram@checksomevotes@checksomevotes_en